Welcome to the 5th mRNA Process Development & CMC Summit
mRNA vaccines and therapeutics remain one of the most promising modalities to transform the treatment of disease indications. However, challenges associated with accurate CMC remain a critical bottleneck, preventing new therapeutics from reaching the market.
Enter the 5th mRNA Process Development & CMC Summit, a 3-day, multi-track, industry-leading conference uniting biopharma’s C-level decision-makers and strategic experts with leading CDMOs, manufacturers, sequencers, and key stakeholders. Together, they share one common goal: define the blueprint for process development strategies that will enable pure, scalable mRNA therapeutics to reach patients through commercially viable solutions.
Join 120+ global experts across process development, analytical, formulation, delivery, and CMC, bringing forward new data and strategies that are shaping the next wave of mRNA development - from circular and self-amplifying RNA, to cutting-edge cell and gene editing applications.
I'm excited to join this summit to exchange practical insights on mRNA process development and to learn new approaches and materials that improve mRNA quality for therapeutics
Jack (Chia Chieh) Chu, Principal Scientist, GSK
I look forward to connecting with scientists and industry leaders working to bring safe and effective mRNA medicines to the clinic
Amit Khandhar, Director, Formulations, HDT Bio
I’m very interested in how the industry will advance the capabilities of circular RNA and overcome LNP CMC hurdles (especially with active binders)
Zimeng Wang, Associate Principal Scientist, AstraZeneca
To network with other mRNA colleagues and hear their perspective on the constantly evolving mRNA field and learn the developments in the analytical and CMC strategy in how to approach the hurdles we face
Shirisha Meda, Associate Director, BioNTech
It is important to discuss how R&D, process development, CMC and manufacturing groups can work together to ensure robust therapeutic development.
T.J. Cradick, Chief Scientific Officer, HuidaGene Therapeutics
Explore the Full Event Guide
- Explore the complete agenda covering mRNA, gene editing, and emerging RNA modalities
- Discover how industry leaders are tackling critical CMC bottlenecks across manufacturing, delivery, and analytics
- Review real-world case studies focused on scalability, purification, and regulatory-ready processes
- Share with your team to align cross-functional CMC, PD, and analytical priorities
World-Class Speaker Faculty Includes:
Official Partners
Previously Attending Companies Include:
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.